Rheumatoid Arthritis Therapeutics Market Size, Share & Trends Report

Rheumatoid Arthritis Therapeutics Market Size, Share & Trends Analysis Report By Molecule (Pharmaceuticals, Biopharmaceuticals), By Sales Channel (Prescription, OTC), By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-2-68038-313-3
Number of Report Pages: 150
Format: PDF, Horizon Databook

Historical Range: 2018 - 2023
Forecast Period: 2024 - 2030
Industry: Healthcare

Market Segmentation

Rheumatoid Arthritis Therapeutics Molecule Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceuticals
  - NSAIDs
  - Analgesics
  - DMARDs
  - Glucocorticoids
- Biopharmaceuticals
  - Biologics
    - TNF-α antagonists
    - T-cell inhibitors
    - CD20 antigen
    - JAK inhibitors
    - anti-IL6 biologics
  - Biosimilars
    - CD20 antigen
    - TNF-α antagonists
Rheumatoid Arthritis Therapeutics Molecule Outlook (Revenue, USD Million, 2018 - 2030)
- Prescription
- Over-the-Counter (OTC)
Rheumatoid Arthritis Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Rheumatoid Arthritis Therapeutics Market, By Molecule
    - Pharmaceuticals
      - NSAIDs
      - Analgesics
      - DMARDs
      - Glucocorticoids
    - Biopharmaceuticals
      - Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
      - Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
  - North America Rheumatoid Arthritis Therapeutics Market, By Sales Channel
    - Prescription
    - Over-the-Counter (OTC)
  - U.S.
    - U.S. Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - U.S. Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Canada
    - Canada Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Canada Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Mexico
    - Mexico Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Mexico Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
- Europe
  - Europe Rheumatoid Arthritis Therapeutics Market, By Molecule
    - Pharmaceuticals
      - NSAIDs
      - Analgesics
      - DMARDs
      - Glucocorticoids
    - Biopharmaceuticals
      - Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
      - Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
  - Europe Rheumatoid Arthritis Therapeutics Market, By Sales Channel
    - Prescription
    - Over-the-Counter (OTC)
  - Germany
    - Germany Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Germany Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - UK
    - UK Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - UK Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - France
    - France Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - France Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Italy
    - Italy Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Italy Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Spain
    - Spain Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - U.S. Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Denmark
    - Denmark Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Denmark Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Sweden
    - Sweden Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Sweden Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Norway
    - Norway Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Norway Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
- Asia Pacific
  - Asia Pacific Rheumatoid Arthritis Therapeutics Market, By Molecule
    - Pharmaceuticals
      - NSAIDs
      - Analgesics
      - DMARDs
      - Glucocorticoids
    - Biopharmaceuticals
      - Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
      - Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
  - Asia Pacific Rheumatoid Arthritis Therapeutics Market, By Sales Channel
    - Prescription
    - Over-the-Counter (OTC)
  - China
    - China Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - China Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Japan
    - U.S. Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - U.S. Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - India
    - India Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - India Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - South Korea
    - South Korea Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - South Korea Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Australia
    - Australia Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Australia Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Thailand
    - Thailand Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Thailand Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
- Latin America
  - Latin America Rheumatoid Arthritis Therapeutics Market, By Molecule
    - Pharmaceuticals
      - NSAIDs
      - Analgesics
      - DMARDs
      - Glucocorticoids
    - Biopharmaceuticals
      - Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
      - Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
  - Latin America Rheumatoid Arthritis Therapeutics Market, By Sales Channel
    - Prescription
    - Over-the-Counter (OTC)
  - Brazil
    - Brazil Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Brazil Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Argentina
    - Argentina Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Argentina Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
- Middle East and Africa (MEA)
  - Middle East and Africa (MEA) Rheumatoid Arthritis Therapeutics Market, By Molecule
    - Pharmaceuticals
      - NSAIDs
      - Analgesics
      - DMARDs
      - Glucocorticoids
    - Biopharmaceuticals
      - Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
      - Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
  - Middle East and Africa (MEA) Rheumatoid Arthritis Therapeutics Market, By Sales Channel
    - Prescription
    - Over-the-Counter (OTC)
  - South Africa
    - South Africa Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - South Africa Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Saudi Arabia
    - Saudi Arabia Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Saudi Arabia Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - Kuwait
    - Kuwait Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - Kuwait Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)
  - UAE
    - UAE Rheumatoid Arthritis Therapeutics Market, By Molecule
      - Pharmaceuticals
        
        NSAIDs
        
        Analgesics
        
        DMARDs
        
        Glucocorticoids
      - Biopharmaceuticals
        
        Biologics
        
        TNF-α antagonists
        
        T-cell inhibitors
        
        CD20 antigen
        
        JAK inhibitors
        
        anti-IL6 biologics
        
        Biosimilars
        
        CD20 antigen
        
        TNF-α antagonists
    - UAE Rheumatoid Arthritis Therapeutics Market, By Sales Channel
      - Prescription
      - Over-the-Counter (OTC)

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.